ArticleBMC microbiology2025
Hitchhiking genes and boundaries of AmpC amplicons during amoxicillin resistance development in E. coli.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuplication and amplification of the chromosomal beta-lactamase gene ampC is a main mechanism for amoxicillin resistance development in E. coli. When E. coli is exposed to step-wise increasing amoxicillin concentrations, a fragment carrying the ampC gene can be amplified to high levels, resulting in up to 500 fold increased transcription of ampC. The size of the amplicon varies between replicates and it is not clear what determines the size and boundaries of the fragment. This study investigates the hypothesis that there are conserved amplicon boundaries and hitchhiking genes in amplified fragment.
resultsSeven mutants were constructed with a deletion of conserved flank-site located genes or hitchhiking genes (∆yjeI, ∆sugE, ∆blc, ∆epmA, ∆yjeM, ∆PecnB and ∆ecnB). The amoxicillin adaptation rates of ∆sugE and ∆epmA were significantly lower than wild type during a 22-day evolution. The duplication or amplification of ampC can be observed in all evolved strains. More genomic point mutations were acquired in evolved ∆epmA and ∆yjeM than in the wild type and other evolved mutants.
conclusionsThe amplification of ampC does not exhibit a fixed hotspot for its boundaries. IS1A frequently serves as an endpoint in ampC duplications in many evolved E. coli strains. The deletion of sugE and epmA genes, which are located near ampC on the chromosome, affects amoxicillin resistance development in E. coli. Hence the hypothesis is mostly falsified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.